Palavra-chave: IMATINIB

MOLECULAR RESPONSE LASOR PHASE 2 STEM CELL TRANSPLANTATION BCR-ABL PHARMAECONOMIC STUDY PROTEIN-CODING LEUCEMIA MIELÓIDE CRÔNICA (LMC) NILOTINIB FRONTLINE DASATINIB BCR-ABL MUTATIONS CYTARABINE CYTOGENETIC REMISSION LEUCEMIA MIELÓDE CRÔNICA BCR/ABL GENE DISCONTINUATION BRAZIL BCR/ABL OCULAR EUTOS SCORE CML TREATMENT-FREE REMISSION CHRONIC MEYLOID LEUKEMIA IRS-1 LALNET RNAS GENERIC CHRONIC MYELOID LEUCEMIA NON-MYELOABLATIVE LOW EDUCATION LEVEL K562 CELLS LEUCEMIA MIELÓIDE CRÔNICA (LMC-PB) CML-CP MR4.5 ANEMIA FALCIFORME CRONIC LYMPHOCYTIC LEUKEMIA TYROSINE KINASE INHIBITORS CHRONIC PHASE TRANSPORTER GENES CHRONIC MYELOID LEUKAEMIA START MITOXANTRONE MOLECULAR FIRST-LINE MYELOGENOUS LEUKEMIA POLYMORPHISMS LEUCEMIA MIELÓIDE CRÔNICA CITARABINA CHRONIC MYELOGENOUS LEUKEMIA MESILATO F359V CHILDREN AND ADOLESCENTS OBSERVATIONAL CYTOGENETIC CHRONIC MYELOID LEUKEMIA CHRONIC MYELOID LEUCEMIA (CML) BCL/ABL DASATINIB-TREATED LEUCEMIA MIELOIDE CRÔNICA KIT K5091